At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 23 Apr 2001 Preclinical development for CNS disorders in Italy (Unknown route)